SAFETY AND TOLERABILITY OF FENTANYL SUBLINGUAL SPRAY DURING THE TITRATION PHASE OF TWO PHASE 3 CLINICAL TRIALS: A POOLED ANALYSIS

被引：0
|
作者：
Rauck, Richard [1 ]
Stearns, Lisa [2 ]
Forman, Nicole [3 ]
Parikh, Neha [3 ]
机构：
[1] Clin Res Ctr, Winston Salem, NC USA
[2] Ctr Pain & Support Care, Scottsdale, AZ USA
[3] Insys Therapeut, Chandler, AZ USA
来源：
ONCOLOGY NURSING FORUM | 2015年 / 42卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页码：E225 / E225
页数：1
相关论文
共 50 条
  • [41] Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
    Lopez-Fauqued, Marta
    Campora, Laura
    Delannois, Frederique
    El Idrissi, Mohamed
    Oostvogels, Lidia
    De Looze, Ferdinandus J.
    Diez-Domingo, Javier
    Heineman, Thomas C.
    Lal, Himal
    McElhaney, Janet E.
    McNeil, Shelly A.
    Yeo, Wilfred
    Tavares-Da-Silva, Fernanda
    Ahonen, Anitta
    Avelino-Silva, Thiago Junquera
    Fernando Barba-Gomez, Jose
    Berglund, Johan
    Brotons Cuixart, Carlos
    Caso, Covadonga
    Chlibek, Roman
    Choi, Won Suk
    Cunningham, Anthony L.
    Desole, Maria Guiseppina
    Eizenberg, Peter
    Esen, Meral
    Espie, Emmanuelle
    Gervais, Pierre
    Ghesquiere, Wayne
    Godeaux, Olivier
    Gorfinkel, Iris
    Hui, David Shu Cheong
    Hwang, Shinn-Jang
    Korhonen, Tiina
    Kovac, Martina
    Ledent, Edouard
    Leung, Edward
    Levin, Myron J.
    Narejos Perez, Silvia
    Neto, Jose Luiz
    Pauksens, Karlis
    Poder, Airi
    Rodriguez de la Pinta, Maria Luisa
    Rombo, Lars
    Schwarz, Tino F.
    Smetana, Jan
    Staniscia, Tommaso
    Tinoco, Juan Carlos
    Toma, Azhar
    Vastiau, Ilse
    Vesikari, Timo
    VACCINE, 2019, 37 (18) : 2482 - 2493
  • [42] Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: A pooled analysis from two controlled phase III clinical studies
    Knopp, RH
    Dujovne, CA
    Le Beaut, A
    Lipka, LJ
    Suresh, R
    Veltri, EP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (05) : 363 - 368
  • [43] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Diener, Hans Christoph
    McAllister, Peter
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Silberstein, Stephen D.
    CEPHALALGIA, 2022, 42 (08) : 769 - 780
  • [44] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
    Vargas, Bert B.
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    McAllister, Peter
    NEUROLOGY, 2020, 94 (15)
  • [45] Safety and Tolerability of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    McAllister, Peter
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    ANNALS OF NEUROLOGY, 2020, 88 : S158 - S159
  • [46] Disease Characteristics Of Asthma Phenotypes: A Pooled Analysis Of Two Phase 2 Clinical Trials
    Busse, W. W.
    Holgate, S. T.
    Wenzel, S. E.
    Lin, S.
    Lin, S. -L.
    Chon, Y.
    Feng, J.
    Nirula, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [47] A pooled analysis of surufatinib safety from phase 3 trials in advanced NETs.
    Li, Jie
    Xu, Jianming
    Shen, Lin
    Bai, Chunmei
    Zhou, Zhiwei
    Li, Zhiping
    Chi, Yihebali
    Yu, Xianjun
    Li, Enxiao
    Xu, Nong
    Liu, Tianshu
    Lou, Wenhui
    Bai, Yuxian
    Yuan, Xianglin
    Wang, Xiuwen
    Yuan, Ying
    Chen, Jia
    Zhang, Tao
    Xiu, Dianrong
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Changes in blood pressure category with erenumab: A pooled analysis of phase 2 and phase 3 clinical trials
    Dodick, D. W.
    Dougherty, C. O.
    Kalidas, K.
    Nelson, R.
    Pannacciulli, N.
    Xue, F.
    Zhang, F.
    Flores-Arredondo, J.
    Choudhry, J.
    HEADACHE, 2021, 61 : 113 - 114
  • [49] Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
    Munoz-Villegas, Patricia
    Navarro-Sanchez, Andrea A.
    Sanchez-Rios, Alejandra
    Olvera-Montano, Oscar
    Baiza-Duran, Leopoldo M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1123 - 1134
  • [50] Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review
    Didier, Alain
    Bons, Brigitte
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 777 - 788
12345